Summary

ES Cell International Pte, Ltd. (ESI) is a regenerative medicine company, based in Singapore. The company develops human embryonic stem cell technologies for research and commercial applications. It develops hES cell technology that consists of the generation of cGMP HESC lines, derivation of HESC-derived cardiomyocytes, the production of neural progenitor cells, technology and IP for diabetes research. ESI has intellectual property in the areas of drug discovery, diagnostics and therapeutics. The company is cGMP certified. It has collaboration with BioTime, Inc. The company operates through its subsidiary, CellCure Neurosciences Ltd that develops neural technology derived from hESCs. ESI is headquartered in Singapore.

ES Cell International Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 4
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare Deals By Type, 2007 to YTD 2013 5
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals By Region, 2007 to YTD 2013 6
ES Cell International Pte Ltd, Medical Devices Deals, 2007 to YTD 2013 7
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals Summary, 2007 to YTD 2013 8
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deal Details 9
Venture Financing 9
Cell Cure Neurosciences Raises US$0.81 Million In Venture Financing 9
Licensing Agreements 11
ES Cell Enters Into Licensing Agreement With ITI Life Sciences 11
Acquisition 12
BioTime Acquires ES Cell International 12
ES Cell International Pte Ltd - Key Competitors 14
Key Employees 15
Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17



List of Tables

ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Key Facts 1
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 1
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals By Region, 2007 to YTD 2013 1
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals Summary, 2007 to YTD 2013 1
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 4
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare Deals By Type, 2007 to YTD 2013 5
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals By Region, 2007 to YTD 2013 6
ES Cell International Pte Ltd, Medical Devices Deals, 2007 to YTD 2013 7
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals Summary, 2007 to YTD 2013 8
Cell Cure Neurosciences Raises US$0.81 Million In Venture Financing 9
ES Cell Enters Into Licensing Agreement With ITI Life Sciences 11
BioTime Acquires ES Cell International 12
ES Cell International Pte Ltd, Key Competitors 14
ES Cell International Pte Ltd, Key Employees 15



List of Figures

ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals by Type, 2007 to YTD 2013 1
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals By Year, 2007 to YTD 2013 4
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals by Type, 2007 to YTD 2013 5
ES Cell International Pte Ltd, Pharmaceuticals and Healthcare, Deals By Region, 2007 to YTD 2013 6
ES Cell International Pte Ltd, Medical Devices Deals, 2007 to YTD 2013 7

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Degenerative Disc Disease - Pipeline Review, H1 2014

Degenerative Disc Disease - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Degenerative Disc Disease - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Degenerative Disc Disease - Pipeline Review, H1 2014', provides an overview of the Degenerative Disc Disease's therapeutic ...

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

World Therapy: Critical Limb Ischemia – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Critical Limb Ischemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

Bioheart, Inc. - Product Pipeline Review - 2014

Bioheart, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • April 2014
  • by Global Markets Direct

Bioheart, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Bioheart, Inc. - Product Pipeline Review - 2014', provides an overview of the Bioheart, Inc.'s pharmaceutical research ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.